This invention discloses a method for preparing recombinant
astaxanthin vesicles derived from
Haematococcus pluvialis with gut-protective and lipid-regulating effects, belonging to the field of
bioactive substance delivery. This
system uses
Haematococcus pluvialis as
raw material, without adding any exogenous carriers, directly extracting natural
astaxanthin and algal lipids, which are then recombined and self-assembled to form a stable nano-
delivery system. Algal lipids serve as the carrier framework,
astaxanthin as the
active ingredient, phospholipids participate in the formation of the
lipid bilayer, and astaxanthin is embedded in the hydrophobic region, achieving efficient delivery and
oral administration. This invention utilizes the synergistic effect of the algal components themselves to solve the problems of poor water
solubility and low
bioavailability of astaxanthin. Combining the lipid-regulating effects of algal lipids with the gut-protective and
antioxidant effects of astaxanthin, it achieves a three-in-one effect of "delivery, protection, gut protection, and lipid regulation." It can be used in functional foods, health products, and pharmaceutical preparations to improve intestinal
microecology and regulate
lipid metabolism, possessing advantages such as natural safety, simple process, low cost, and broad application prospects.